English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China; Department of GCP, Clinical Research Department, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou 510060, China; Department of Medical Oncology, Anhui Provincial Hospital, Hefei 230001, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China Contributions: (I) Conception and design: MZ Qiu, FH Wang, S Li; (II) Administrative support: S Li, FH Wang; (III) Provision of study materials or patients: MZ Qiu, FH Wang; (IV) Collection and assembly of data: J Sun, Y Zhang, T Mei; (V) Data analysis and interpretation: J Sun, MZ Qiu ,B Chang, Y Gao; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. These authors contributed equally to this work. Correspondence to: Feng-Hua Wang. Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China. Email: wangfh@sysucc.org.cn; Su Li. Department of GCP, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East, Guangzhou 510060, China. Email: lisu@sysucc.org.cn.

translational cancer research

Dynamic monitoring of serum soluble programmed cell death ligand 1 as a response predictor to chemotherapy in metastatic or recurrent gastrointestinal cancer